Healthcare / Health Information ServicesLSE
$145.40
+1.40 (+0.97%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 23%
FCF escenarios
weak_data · normalized FCF $-4.0M · quality 68.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
43/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$123M
P/E
132181.7x
↑EV/EBITDA
2004.4x
↑ROE
0.2%
↓Gross Margin
81.9%
↑Debt/Equity
0.03
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+25.4%
FCF CAGR
—
FCF margin
-13.7%
FCF / Net income
-54.32x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $38.4M · net income $97000.0 · FCF $-5.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $38.4M | $38.4M | $32.2M | $23.7M | $19.5M |
| Net Income | $97000.00 | $97000.00 | $-1.7M | $-1.7M | $724000.00 |
| EBITDA | $6.2M | $6.2M | $2.8M | $2.4M | $3.7M |
| EPS | 0.00 | 0.00 | — | -0.02 | 0.01 |
| Gross Margin | 81.9% | 81.9% | 87.9% | 83.2% | 85.8% |
| Operating Margin | 0.1% | 0.1% | -7.6% | -12.7% | 2.9% |
| Net Margin | 0.3% | 0.3% | -5.3% | -7.4% | 3.7% |
| Balance Sheet | |||||
| Debt/Equity | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Current Ratio | 3.43 | 3.43 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-5.3M | $-5.3M | $-4.0M | $-3.5M | $226000.00 |
| Returns | |||||
| ROE | 0.2% | 0.2% | -4.3% | -4.3% | 1.7% |
| Valuation | |||||
| P/E | 132181.73 | 132181.73 | — | — | 9226.19 |
| EV/EBITDA | 2004.39 | 2004.39 | 4156.35 | 3098.13 | 1802.12 |
| P/B | 305.76 | 305.76 | 289.47 | 182.76 | 156.94 |
| Growth & Yield | |||||
| Revenue Growth | 19.5% | 19.5% | 35.7% | 21.5% | — |
| EPS Growth | — | — | — | -346.4% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
2172.1%
EPS terminal req.
$12.90
Spread vs growth
-2152.5%
5Y implied EPS CAGR
576.7%
EPS terminal req.
$15.61
Spread vs growth
-557.2%
10Y implied EPS CAGR
172.8%
EPS terminal req.
$25.14
Spread vs growth
-153.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+12.7%
Start / end P/E
n/dx → n/dx
EPS bridge
n/d → 0.00
Residual
+12.7%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.